ESTRO 2024 - Abstract Book

S425

Brachytherapy - Urology

ESTRO 2024

1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021 May;71(3):209 – 49. 2. Agarwal PK, Sadetsky N, Konety BR, Resnick MI, Carroll PR, Cancer of the Prostate Strategic Urological Research Endeavor (CaPSURE). Treatment failure after primary and salvage therapy for prostate cancer: likelihood, patterns of care, and outcomes. Cancer. 2008 Jan 15;112(2):307 – 14. 3. Quero L, Vercellino L, de Kerviler E, Mongiat-Artus P, Culine S, Merlet P, et al. 18F-Choline PET/CT and Prostate MRI for Staging Patients With Biochemical Relapse After Irradiation for Prostate Cancer. Clin Nucl Med. 2015 Nov;40(11):e492-495. 4. Morigi JJ, Stricker PD, van Leeuwen PJ, Tang R, Ho B, Nguyen Q, et al. Prospective Comparison of 18F Fluoromethylcholine Versus 68Ga-PSMA PET/CT in Prostate Cancer Patients Who Have Rising PSA After Curative Treatment and Are Being Considered for Targeted Therapy. J Nucl Med Off Publ Soc Nucl Med. 2015 Aug;56(8):1185 – 90.

5. H T, J K, T P, S T, Pc B. Underutilization of local salvage therapy after radiation therapy for prostate cancer. Urol Oncol [Internet]. 2014 Jul [cited 2023 Feb 26];32(5). Available from: https://pubmed.ncbi.nlm.nih.gov/24629499/

6. Ahmadi H, Daneshmand S. Androgen deprivation therapy: evidence-based management of side effects. BJU Int. 2013 Apr;111(4):543 – 8.

7. Harris WP, Mostaghel EA, Nelson PS, Montgomery B. Androgen deprivation therapy: progress in understanding mechanisms of resistance and optimizing androgen depletion. Nat Clin Pract Urol. 2009 Feb;6(2):76 – 85.

8. Coen JJ, Zietman AL, Thakral H, Shipley WU. Radical radiation for localized prostate cancer: local persistence of disease results in a late wave of metastases. J Clin Oncol Off J Am Soc Clin Oncol. 2002 Aug 1;20(15):3199 – 205.

9. Kishan AU, Chu FI, King CR, Seiferheld W, Spratt DE, Tran P, et al. Local Failure and Survival After Definitive Radiotherapy for Aggressive Prostate Cancer: An Individual Patient-level Meta-analysis of Six Randomized Trials. Eur Urol. 2020 Feb;77(2):201 – 8. 10. Valle LF, Lehrer EJ, Markovic D, Elashoff D, Levin-Epstein R, Karnes RJ, et al. A Systematic Review and Meta analysis of Local Salvage Therapies After Radiotherapy for Prostate Cancer (MASTER). Eur Urol. 2021 Sep;80(3):280 – 92.

11. Zhong J, Slevin F, Scarsbrook AF, Serra M, Choudhury A, Hoskin PJ, et al. Salvage Reirradiation Options for Locally Recurrent Prostate Cancer: A Systematic Review. Front Oncol. 2021;11:681448.

12. Lewin R, Amit U, Laufer M, Berger R, Dotan Z, Domachevsky L, et al. Salvage re-irradiation using stereotactic body radiation therapy for locally recurrent prostate cancer: the impact of castration sensitivity on treatment outcomes. Radiat Oncol Lond Engl. 2021 Jun 23;16(1):114. 13. Perera M, Papa N, Roberts M, Williams M, Udovicich C, Vela I, et al. Gallium-68 Prostate-specific Membrane Antigen Positron Emission Tomography in Advanced Prostate Cancer-Updated Diagnostic Utility, Sensitivity, Specificity, and Distribution of Prostate-specific Membrane Antigen-avid Lesions: A Systematic Review and Meta analysis. Eur Urol. 2020 Apr;77(4):403 – 17.